Background and Aims Crohn's disease (CD) is an inflammatory bowel disease (IBD) caused by a combination of genetic, clinical, and environmental factors. Identification of CD patients at high risk of requiring surgery may assist clinicians to decide on a top-down or step-up treatment approach. Methods We conducted a retrospective case-control analysis of a population-based cohort of 503 CD patients. A regressionbased data reduction approach was used to systematically analyse 63 genomic, clinical and environmental factors for association with IBD-related surgery as the primary outcome variable. Results A multi-factor model was identified that yielded the highest predictive accuracy for need for surgery. The factors included in the model were the NOD2 genotype (OR=1.607, P=2.3×10 −5 ), having ever had perianal disease (OR=2.847, P=4×10 −6 ), being post-diagnosis smokers (OR=6.312, P=7.4×10 −3 ), being an ex-smoker at diagnosis (OR=2.405,
Introduction
Crohn's disease (CD) is believed to be a consequence of multi-factorial interactions between genetic, immunerelated, environmental and microbial triggers that combine to influence the clinical development and progression of this disease. 1 CD has a relapsing-remitting course and treatment depends on controlling disease symptoms and maintaining remission. However, a majority of CD patients require surgery within the first 10 years of diagnosis.
2 Current treatment strategies include the top-down and the step-up approach, the former having evolved from the impact of antitumour necrosis factor (anti-TNF) therapies. 3 However, there is currently no definitive clinical strategy for clinicians to decide which treatment strategy should be used at diagnosis. CD encompasses a wide range of phenotypes and clinical outcomes that may be determined by the genetic make-up or environmental exposures of an individual. These characteristics and outcomes may inform the clinician as to the therapeutic strategy to adopt, for example early aggressive therapy for those patients who are most likely to progress to surgery. 2, 3 A range of factors have been associated with an increased risk of complicated (stricturing and penetrating) CD behaviour including the specific NOD2 genotypes [4] [5] [6] having had perianal disease [8] [9] [10] [11] and cigarette smoking. 1, 6, 8, [12] [13] [14] Complicated disease is strongly associated with a requirement for surgery 15 ; therefore, knowledge of such genetic, environmental and clinical predictors may guide clinicians in developing a personalised approach for individual patients. 2, 3, 16 The ability to predict those who will have a more indolent disease course is also important given the range of adverse drug reactions and the cost of anti-TNF drugs. 3, 17 There is a lack of data concerning which patients would benefit most from a top-down or bottom-up treatment strategy. This highlights the need for better and more accurate prognostic and diagnostic tests for predicting clinical outcomes for CD patients.
This study aims to identify envirogenomic risk factors of the need for surgery as a clinical outcome for CD patients from a population based cohort. The use of any single causative risk factor for diagnosing the development of complicated CD forms is unreliable. Hence, it is expected that by combining information from multiple environmental, clinical and genetic factors, we will be able to develop more accurate personalised profiles that can be used for the early treatment of CD patients. 
Materials and Methods

Patient Selection and Data Ascertainment
This study was a retrospective case control analysis of existing data obtained from a population-based CD cohort. 6 The selection of patients, their data collection, as well as DNA extraction and genotyping was previously performed as part of the Canterbury Inflammatory Bowel Disease (IBD) Project. 6, 7 Briefly, all patients were diagnosed with CD and phenotyped using the Montreal Classification System (MCS). 6, 7 Clinical data were gathered for 715 CD patients in the Canterbury IBD study. Genotype data were available for 503 patients. Eight single nucleotide polymorphisms for seven genes and three variants of the NOD2 gene were genotyped for the 503 patient case studies with CD from the Canterbury IBD cohort. Genotyped patients included 306 females and 197 males. These were the only genetic data available from the original Canterbury IBD project. The average age of the patients was 45 years, and the average disease duration was 9 years (no subsequent follow-up date was available at the time of analysis). Disease behaviour was classified using the MCS, and 160 patients were diagnosed with stricturing disease behaviour, 57 patients with penetrating and 286 patients with non-stricturing non-penetrating disease behaviour. A total of 211 patients had colonic disease location, 166 with ileal location and 126 with ileocolonic disease location. A total of 63 variables including genetic, environmental and clinical factors were analysed as part of this study. Environmental data were collected using a selfadministered questionnaire. 6 The primary outcome variable was the need for any type of IBD-related surgery in CD patients. This outcome variable was generalised to include all types of IBD-related surgical resections as determined from patient records by the lead investigative clinicians (RG and MB) at the time of recruitment. Because this information did not form a primary outcome in the main study, more detailed data regarding the specific type, location and reason for resection were not available. A total of 174 cases had at least one IBD-related surgery within this cohort and 329 had never had IBD-related surgery at the time of recruitment.
Statistical Analysis
In analysing the data, a step-wise data reduction approach was used with the aim of identifying "envirogenomic" profiles that predict risk of surgery in CD patients. Using a systematic approach, the multiple clinical, genetic and environmental factors were logically analysed and reduced down to significantly associated factors using the need for surgical intervention as the primary outcome variable. All significantly associated factors from the genetic, clinical and environmental data analysis were then combined to produce a significantly associated single multi-factor model which identified the patient as being either at risk or with no risk for the need of surgical intervention ( Supplementary Fig. 1 ). Genotype data were cleaned and sorted to create files suitable for analysis in PLINK and SPSS, and disease risk phenotype was incorporated into this file for further analyses. These data were examined for any discrepancies with original studies performed on the same cohort and no differences were found. The systematic five-step analysis strategy was performed as follows (see also Supplementary Fig. 2 ).
Step one-using the software package PLINK, standard case-control analyses were performed to test for association between gene variants and the need for surgery as the clinical outcome (model option). This identified the genetic factors associated with the primary clinical outcome.
Step two-using SPSS, clinical factors were statistically analysed using unadjusted multi-factor logistic regression models. All clinical factors were divided into two variable subgroups: (1) disease history and (2) medical treatment history. After a preliminary model analysis, adjustments using forward conditioning were performed as part of the logistic regression analysis and significant factors were entered into the model.
Step three-all environmental factors were divided into three groups of variables for this analysis: (1) smoking exposure, (2) diet and (3) household. SPSS was then used to perform an unadjusted multiple logistic regression model. After the preliminary model analysis, forward conditioning was performed by using the subsequently analysed factors that were entered into the model.
Step four-this step involved a multi-factor analysis, model, by taking all of the previously significantly associated factors from all adjusted individual models that arose from analysis in previous steps and entered into a forward conditioned multiple logistic regression model collectively.
The multi-factor model was also adjusted for age and sex.
Step five-after identification of significantly associated predicting factors of the need for surgery, stepwise statistical diagnostic tests were performed to verify the predictive probability and accuracy of the multi-factor envirogenomic risk profile model ( Supplementary Fig. 2 ).
Results
Step One: Genomic Factor Analysis PLINK analysis of the gene variants considered separately revealed that the NOD2 genotype was the sole factor significantly associated with the need for surgery in this CD patient cohort (Table 1) . After running binary logistic regression using stepwise forward conditioning on all variants the NOD2 gene still remained as the most significantly associated risk factor for need for surgery in the cohort (OR=1.601, P=1.6×10 −3 ) ( Table 2 ).
Step Two: Clinical Factor Analysis The 26 clinical factors were divided into two groups of variables: (1) disease history and (2) medical treatment history. Disease history variables included variables relating to the history of any type of disease/illness for each patient. Medical treatment history variables included variables relating to the patients history of any type of medical treatment. Disease history-the unadjusted logistic regression analysis model for the 13 factors within this group is shown in Table 3 . Table 3 shows the adjusted multiple forward conditioning logistic regression analytical model. The final model shows that after stepwise data reduction analysis those patients who had ever had perianal disease (OR=2.695, P=1×10 −4 ) were more likely to require surgery. Medical treatment history-the unadjusted logistic regression analysis model for the 13 factors within this group is shown in Table 4 . The final adjusted step wise forward conditioning regression model showed that there were no significantly associated variables from this group of factors.
Step Three: Environmental Factor Analysis The 28 environmental factors were divided into three groups of variables:
(1) smoking, (2) diet and (3) household. Smoking variables included all variables related to smoking. Diet variables included all variables relating to the patients diet. Household variables included all variables relating to the patients household characteristics. Smoking-there were 6 factors that were included in this group of variables that were analysed using unadjusted logistic regression analysis (Table 5 ). In the next step, step wise forward conditioning logistic regression analysis was performed on these 6 factors and the model (Table 5) shows that after the data reduction analysis those patients who were post-diagnosis smokers (OR=5.359, P=1.200×10 −3 ) or ex-smokers at diagnosis (OR=2.706, P=1×10 −4 ) remain as significantly associated with the need for surgery. Diet-this group of variables had 6 factors and after unadjusted regression and a step wise forward conditioning data reduction; no factors were seen as significantly associated with the need for surgery (Table 6 ). Household-a total of 16 factors were analysed within this group of variables. After unadjusted logistic regression models and adjusted forward conditioning regression models were created no factors showed any significant association with the need for surgery (Table 7) . Step Four: Multi-factor Analysis After analysing all of the genetic, clinical and environmental factors independently, the next step involved taking all of the significantly associated variables from each of these three factor groups and analysing them collectively. The factors NOD2 gene, perianal disease, ex-smoker at diagnosis and post-diagnosis smoker stood out as significant and all these factors underwent a forward conditioning logistic regression multi-factor model analysis ( Table 8 ). The next step involved using our combined multi-factor model and adjusting the results for age and gender. The final, adjusted multi-factor model showed that current age (OR=1.012, P=4.4×10
) was significantly associated with the need for surgery along with the four previously identified factors which included the NOD2 gene (OR=1.607, P=2.3×10 -5 ), perianal disease (OR=2.847, P=4×10 ) and post-diagnosis smoker (OR=6.312, P=7.4×10 −3 ) ( Table 9 ). In the final model, age was also associated with the outcome (OR =1.012,
). Figure 1 shows the final regression equation that can be derived from the final multi-factor envirogenomic model.
Step Five: Diagnostic Testing To test the predictive value of the final combined model derived from the previous analytical steps, various investigative tests were performed on the individual probabilities generated form the regression model. First, ROC curves displaying the AUC were created for the combined multi-factor model as well as for models of the clinical, environmental and genetic factors considered individually (Fig. 2) . For the individual factor, the genomic model produced an AUC of 56 % (P=3.7×10 When genomic and clinical factors are combined the AUC slightly increases to 63 % (P=1×10 −4 ) and when clinical and environmental factors are combined the AUC also increases slightly to 65 % (P=1×10 −4 ). Whilst the individual factor models offered some predictive value it was found that the multi-factor envirogenomic model produced the highest predictive value of (AUC=0.68, P=1×10 -4 ) (Table 10) , and hence this model was used for further diagnostic testing. In order to dichotomise our curve, and hence stratify the patients into either a high risk or a low risk category, an optimal cutoff point needed to be chosen. To do this, two points were selected at 80 % sensitivity and 80 % 1-specificity (Fig. 3) . Diagnostic calculations were performed on both cutoff points (Table 11) , and it was found that the second cutoff point at 80 % 1 (specificity) showed the higher odds ratio (OR=3.169, P=1×10 −4 ), higher positive predictive values (0.545) and also had a higher attributable risk (0.271).
Discussion
Many studies have shown that besides genetic factors, clinical and environmental factors are also explanatory components of the pathogenesis of CD and are primarily responsible for its growing incidence around the globe. 6, 7, [17] [18] [19] The natural disease course for CD is highly variable among patients ranging from mild cases requiring dietary modification to severe cases requiring surgery. Therefore, clinicians need to be accurate in their diagnosis and prediction of disease progression when treating patients in order to personalise medical therapy and optimise outcome. This involves not only assessing clinical risk factors but also the growing number of genetic and environmental risk factors associated with disease progression and outcome. Early intervention and diagnosis is necessary for patients so that optimal treatment can be achieved and progressive disease symptoms can be avoided. One goal of clinicians is to utilise predictive factors to accurately categorise patients as either high or low risk for requiring surgery. Hence, clinicians could use such algorithms to select the optimal treatment approaches and deliver personalised medicine. This could include top-down therapy for those with higher risk and a more traditional approach for those with a lower risk of requiring subsequent surgery.
Researchers to date have been able to identify individual factors that are associated with increased risk of complicated CD and risk IBD-related surgery, however utilising individual risk factors for prognostic purposes has not been widely used in practice because of the limited predictive accuracy for any single risk factor. The multi-factor method applied to this population-based IBD cohort has identified genetic, clinical and environmental factors that can be combined to predict the need for IBD-related surgery in CD patients. The multi-factor envirogenomic model included NOD2 genotype, perianal disease, and smoking and age factors and yielded increased predictive value over each factor when considered individually.
The NOD2 gene variants have been previously associated with the risk of developing complicated CD. [4] [5] [6] [7] [8] 18 Smoking has also been associated with the development and progression of CD, 6, 8, [12] [13] [14] 18 increasing the risk for IBD-related surgery. Similarly, perianal disease is associated with an increased risk of progressive complicated CD [8] [9] [10] [11] and resectional surgery. Others have also demonstrated the clinical utility of combining clinical, serological and genetic CD data to predict the progression and severity of CD. 20 We have also previously shown that the risk of surgery is associated with combined genetic and clinical factors-NOD2 genotype and perianal disease. However studies where clinical, genetic and environmental data have been combined and analysed in a systematic way to yield an envirogenomic profile for estimating the risk of complicated disease and surgical intervention have not been performed previously. Previous studies have also shown independent predictor models for various individual risk factors 14 as well as formulated tools to predict the development of complicated CD using independent risk factors 17 ; however, the multifactor model developed in this study produces a much higher predictive probability for the risk of surgery then when any of the risk factors are considered independently, indicating the usefulness of the method of research utilised in this study. Consequently, our multi-factor envirogenomic risk model has taken a step closer to identifying patients at risk for the need of surgery potentially allowing early and personalised therapeutic decisions to be made that can prevent the development of complicated disease.
From this study, it can be concluded that CD patients from this New Zealand population who possess these clinical, genetic and environmental disease factors are at higher risk of IBD-related surgery. Further analyses of other large and well-characterised cohorts, including prospective assessment, may confirm these findings, and it is also possible that other Cutoff 1=80 % (sensitivity); cutoff 2=80 % 1 (specificity)
PPV positive predictive values, NPV negative predictive values, RR relative risk Fig. 3 Cutoff point selection and diagnostic risk division makers of disease severity and prognosis may be able to be integrated into this model. This and related research highlights the clinical usefulness of genomic, epidemiological and clinical research in predicting outcomes for patients with CD.
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